Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deacetoxycephalosporin-C synthase (DAOCS) is a mononuclear, ferrous-dependent oxygenase enzyme (EC 1.14.20.1) essential in the biosynthesis of cephalosporin antibiotics in fungi such as *Acremonium chrysogenum* and bacteria like *Streptomyces clavuligerus*.[2][3][4][5][8] It catalyzes the ring expansion of penicillin N into deacetoxycephalosporin C, a key transformation in converting penicillins into cephalosporins.[4][5][7][8] The enzyme requires 2-oxoglutarate, molecular oxygen, and Fe(II) as cofactors, producing succinate, CO2, and H2O as byproducts.[2][4] DAOCS is a central biosynthetic target in industrial production of cephalosporin antibiotics and substrate engineering[3][7]. Isoforms with varying substrate specificity have been identified in multiple actinomycetes and fungi[7].
Catalyzes the ring expansion of penicillin N to deacetoxycephalosporin C by oxidative cyclization using molecular oxygen and 2-oxoglutarate as cofactors[2][3][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deacetoxycephalosporin-C synthase (DAOCS).